Cat. No.: DMM-001289
| Status | Age | Sex |
|---|---|---|
|
|
|
| Model Overview | |
|---|---|
| Model Description | These hIGFBP-1 (insulin-like growth factor binding protein 1, human) transgenic mice may be useful in studying metabolic and vascular homeostasis, diabetes, and the role of insulin-like growth factor binding protein in placentation and preeclampsia. |
| Strain Name | B6.Cg-Tg(IGFBP1)2Miel/J |
| Background Strain | C57BL and CBA |
| SPF | Yes |
| Research Application | Diabetes |
| Target Information | |
|---|---|
| Target Name | transgene insertion 2 |
| Synonyms | c1:2-2,hIGFBP-1 (line c1:2-2) |
| Gene ID | - |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.